Daiichi Sankyo, Eli Lilly say FDA' Cardio Renal Advisory Committee
RTT News, NY - 1 hour ago
(RTTNews) - Wednesday, Daiichi Sankyo Co., Ltd. and Eli Lilly and Co. (LLY: News ) confirmed that the US Food and Drug Administration's Cardiovascular and
FDA Cardio Renal Advisory Committee to Review Daiichi Sankyo MarketWatch (press release)
FDA tosses Lilly another delay on blood thinner Indianapolis Business Journal
all 21 news articles